HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-François Tanguay Selected Research

inclacumab

11/2016Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT-ACS Trial.
5/2013Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-François Tanguay Research Topics

Disease

19Thrombosis (Thrombus)
10/2022 - 04/2003
18Hemorrhage
10/2022 - 05/2009
16Myocardial Infarction
10/2022 - 06/2007
12Acute Coronary Syndrome
10/2022 - 10/2003
11Coronary Artery Disease (Coronary Atherosclerosis)
10/2022 - 09/2003
11ST Elevation Myocardial Infarction
09/2021 - 07/2010
7Cardiovascular Diseases (Cardiovascular Disease)
10/2022 - 03/2011
5Inflammation (Inflammations)
01/2021 - 06/2004
5Stroke (Strokes)
10/2015 - 03/2011
4Hyperplasia
01/2008 - 07/2003
3Fibrosis (Cirrhosis)
10/2019 - 07/2003
3Non-ST Elevated Myocardial Infarction
01/2016 - 05/2013
3Vascular Diseases (Vascular Disease)
08/2014 - 03/2011
2Death (Near-Death Experience)
06/2021 - 01/2020
2Heart Diseases (Heart Disease)
10/2019 - 02/2012
2Coronary Disease (Coronary Heart Disease)
01/2019 - 03/2018
2Diabetes Mellitus
01/2019 - 05/2016
2Atrial Fibrillation
01/2018 - 01/2012
2Vascular Remodeling
05/2015 - 11/2004
2Myocardial Ischemia (Ischemic Heart Diseases)
02/2015 - 10/2010
2Atherosclerosis
08/2013 - 01/2013
2Ischemic Stroke
01/2012 - 10/2003
2Peripheral Arterial Disease
05/2011 - 03/2011
2Heart Failure
03/2008 - 10/2003
2Neointima
01/2008 - 06/2004
1Unstable Angina
10/2022
1COVID-19
09/2021
1AIDS-Related Complex (ARC)
06/2021
1Pulmonary Hypertension
01/2021
1Infarction (Infarctions)
11/2020
1Renal Insufficiency (Renal Failure)
01/2020
1Hypertrophy
10/2019
1Heart Arrest (Cardiac Arrest)
09/2019
1Hypertension (High Blood Pressure)
05/2015
1Infections
08/2014
1Transient Ischemic Attack
11/2013
1Type 2 Diabetes Mellitus (MODY)
11/2012
1Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2011
1Weight Gain
12/2011
1Body Weight (Weight, Body)
12/2011
1Obesity
12/2011

Drug/Important Bio-Agent (IBA)

11Clopidogrel (Plavix)FDA Link
10/2022 - 10/2003
10Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2022 - 10/2003
4Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
10/2022 - 03/2011
4MetalsIBA
06/2021 - 01/2008
4Prasugrel HydrochlorideFDA Link
06/2021 - 11/2013
4Pharmaceutical PreparationsIBA
01/2021 - 10/2015
3Purinergic P2Y Receptor AntagonistsIBA
06/2021 - 10/2003
32'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2020 - 10/2015
3Proton Pump InhibitorsIBA
11/2013 - 03/2011
2TicagrelorIBA
06/2021 - 11/2013
2MonocrotalineIBA
01/2021 - 10/2019
2AnticoagulantsIBA
01/2020 - 01/2018
2EverolimusFDA Link
12/2017 - 10/2017
2P-SelectinIBA
11/2016 - 05/2013
2inclacumabIBA
11/2016 - 05/2013
2thienopyridineIBA
05/2016 - 10/2015
2StreptokinaseFDA Link
01/2016 - 03/2011
2Enoxaparin (Lovenox)FDA LinkGeneric
01/2016 - 05/2011
2NestinIBA
05/2015 - 08/2014
2Proteins (Proteins, Gene)FDA Link
08/2014 - 01/2013
2Warfarin (Coumadin)FDA LinkGeneric
05/2011 - 03/2011
2Phenobarbital (Luminal)FDA Link
11/2004 - 06/2004
1insulin receptor-related receptor (IRR)IBA
09/2021
1AntithrombinsIBA
11/2020
1PolymersIBA
01/2020
1APTIBA
01/2018
1Monoclonal AntibodiesIBA
11/2016
1salicylhydroxamic acid (SHAM)IBA
02/2015
1Glycoproteins (Glycoprotein)IBA
12/2014
1DNA (Deoxyribonucleic Acid)IBA
08/2014
1Eptifibatide (Integrilin)FDA Link
10/2013
1omega-Chloroacetophenone (Mace)IBA
08/2013
1Biomarkers (Surrogate Marker)IBA
01/2013
1C-Reactive ProteinIBA
01/2013
1Estrogen ReceptorsIBA
12/2012
1Nonesterified Fatty Acids (NEFA)IBA
11/2012
1Insulin (Novolin)FDA Link
11/2012
1Liposomes (Liposome)IBA
02/2012
1Contrast MediaIBA
02/2012
1LeptinIBA
12/2011
1Fatty Acids (Saturated Fatty Acids)IBA
12/2011
1Messenger RNA (mRNA)IBA
12/2011
1ARC 1779IBA
11/2011
1von Willebrand FactorIBA
11/2011
1Fondaparinux (Arixtra)FDA Link
05/2011
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2010

Therapy/Procedure

22Therapeutics
10/2022 - 02/2007
22Stents
10/2022 - 10/2003
18Percutaneous Coronary Intervention
10/2022 - 01/2008
9Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2021 - 01/2008
8Drug-Eluting Stents
06/2021 - 02/2007
6Secondary Prevention
10/2022 - 03/2011
2Intraperitoneal Injections
01/2021 - 10/2019
1Induced Hypothermia
09/2019
1Transcatheter Aortic Valve Replacement
01/2018
1Precision Medicine
02/2012
1Cell- and Tissue-Based Therapy (Cell Therapy)
10/2010
1Transplantation
10/2010
1Contraindications
01/2010